Product Information
FAMOTIDINE 40 MG/5 ML SUSP is a generic product labeled by Ascend Laboratories, LLC, priced at $0.1305 per ML under NDC 67877077589. Its NADAC has been published 152 times since Nov 8, 2023.
FDA first approved this application on May 15, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/5mL
Manufacturer
Ascend Laboratories, LLCNDC
67877077589
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FAMOTIDINEApproval Type
Generic (ANDA)
FDA Application
ANDA216400FDA Approved
5/15/2023
TE Code
AB
On Market Since
8/24/2023
Pharmacological Classes
Price Statistics
The NADAC for FAMOTIDINE 40 MG/5 ML SUSP has been published 152 times since Nov 8, 2023, and over the history we have for it it has declined 76.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1305 per ML |
|---|---|
| All-time high | $0.6220 (Mar 13, 2024) |
| All-time low | $0.1305 (Sep 23, 2026) |
| 52-week high | $0.2148 |
| 52-week low | $0.1305 |
| Median price | $0.2752 |
| Average price | $0.3145 |
| Largest weekly change | +39.5% (Aug 21, 2024) |
| Weeks tracked | 152 |
| Tracking since | Nov 8, 2023 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ascend Laboratories, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Famotidine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-2 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FAMOTIDINE 40 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for FAMOTIDINE 40 MG/5 ML SUSP, manufactured by Ascend Laboratories, LLC, is $0.1305 per ML (NDC 67877077589), effective Sep 30, 2026.
How has the price of FAMOTIDINE 40 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for FAMOTIDINE 40 MG/5 ML SUSP has declined 76.5%. It has been tracked across 152 weekly CMS publications since Nov 8, 2023.
What are the highest and lowest recorded NADAC prices for FAMOTIDINE 40 MG/5 ML SUSP?
Since Nov 8, 2023, the NADAC for FAMOTIDINE 40 MG/5 ML SUSP has ranged from a low of $0.1305 (Sep 23, 2026) to a high of $0.6220 (Mar 13, 2024), with a median of $0.2752 per ML.
Are there cheaper alternatives to FAMOTIDINE 40 MG/5 ML SUSP?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FAMOTIDINE 40 MG/5 ML SUSP in a comparable dosage form, but none are currently priced below it.
Who manufactures FAMOTIDINE 40 MG/5 ML SUSP?
FAMOTIDINE 40 MG/5 ML SUSP (NDC 67877077589) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.